Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$885K Buy
2,444
+109
+5% +$37.3K 0.48% 51
2026
Q1
$821K Buy
2,335
+97
+4% +$34.6K 0.55% 48
2025
Q4
$732K Buy
2,238
+41
+2% +$13K 0.5% 52
2025
Q3
$620K Buy
2,197
+74
+3% +$21.5K 0.43% 58
2025
Q2
$593K Sell
2,123
-64
-3% -$18.1K 0.48% 57
2025
Q1
$681K Buy
2,187
+97
+5% +$28.6K 0.65% 51
2024
Q4
$545K Buy
+2,090
New +$620K 0.56% 61

Other funds holding AMGN

WinCap Financial's AMGN Position: Q2 2026 in Review

WinCap Financial increased its Amgen (AMGN) stake by 4.7% in Q2 2026, buying an estimated $37.3K and bringing the position to 2,444 shares worth $885K. The position accounts for 0.48% of the portfolio, ranked #51.

WinCap Financial first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • WinCap Financial held 2,444 shares of Amgen worth $885K as of Q2 2026.
  • WinCap Financial bought 109 Amgen shares in Q2 2026, an estimated $37.3K.
  • Amgen made up 0.48% of WinCap Financial's portfolio in Q2 2026, its #51 holding.
  • WinCap Financial first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on WinCap Financial's 13F filing for Q2 2026, filed 9 Jul 2026.